0000950170-23-029411.txt : 20230622
0000950170-23-029411.hdr.sgml : 20230622
20230622161353
ACCESSION NUMBER: 0000950170-23-029411
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230622
DATE AS OF CHANGE: 20230622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JONAS JEFFREY M
CENTRAL INDEX KEY: 0001042021
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 231033452
MAIL ADDRESS:
STREET 1: ROBERTS SHERIDAN & KOTEL
STREET 2: 12 EAST 49TH STREET 30TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0407
4
2023-06-20
0001771917
Karuna Therapeutics, Inc.
KRTX
0001042021
JONAS JEFFREY M
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
true
false
false
false
false
Common Stock
2023-06-20
4
A
false
990
0
A
990
D
Option (right to buy)
237.70
2023-06-20
4
A
false
1904
0
A
2033-06-19
Common Stock
1904
1904
D
Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates.
This option shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates.
/s/ Troy Ignelzi, Attorney-in-Fact
2023-06-22